Rank | Gene Set | Z-score |
---|---|---|
1 | keratinocyte differentiation (GO:0030216) | 9.20451553 |
2 | detection of light stimulus involved in sensory perception (GO:0050962) | 9.12641184 |
3 | detection of light stimulus involved in visual perception (GO:0050908) | 9.12641184 |
4 | * photoreceptor cell maintenance (GO:0045494) | 8.94452570 |
5 | photoreceptor cell development (GO:0042461) | 8.82631284 |
6 | eye photoreceptor cell development (GO:0042462) | 8.55001024 |
7 | multicellular organismal water homeostasis (GO:0050891) | 8.39336510 |
8 | positive regulation of guanylate cyclase activity (GO:0031284) | 7.51615387 |
9 | * phototransduction (GO:0007602) | 7.20698135 |
10 | peptide cross-linking (GO:0018149) | 7.18604364 |
11 | epidermal cell differentiation (GO:0009913) | 7.12520268 |
12 | * detection of light stimulus (GO:0009583) | 7.10663938 |
13 | * phototransduction, visible light (GO:0007603) | 7.02437478 |
14 | * detection of visible light (GO:0009584) | 7.02352093 |
15 | water homeostasis (GO:0030104) | 6.98176435 |
16 | retinal rod cell development (GO:0046548) | 6.91517964 |
17 | GMP metabolic process (GO:0046037) | 6.79491647 |
18 | regulation of guanylate cyclase activity (GO:0031282) | 6.71334350 |
19 | photoreceptor cell differentiation (GO:0046530) | 6.47022490 |
20 | eye photoreceptor cell differentiation (GO:0001754) | 6.47022490 |
21 | * visual perception (GO:0007601) | 6.44296500 |
22 | * sensory perception of light stimulus (GO:0050953) | 6.38831392 |
23 | epidermis development (GO:0008544) | 6.15355940 |
24 | intermediate filament organization (GO:0045109) | 6.00392261 |
25 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 5.64379557 |
26 | protein-chromophore linkage (GO:0018298) | 5.62052548 |
27 | linoleic acid metabolic process (GO:0043651) | 5.38042920 |
28 | cellular response to antibiotic (GO:0071236) | 5.30092337 |
29 | cellular response to light stimulus (GO:0071482) | 5.21593015 |
30 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 5.15670503 |
31 | lipoxygenase pathway (GO:0019372) | 5.12415859 |
32 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.06635290 |
33 | retina development in camera-type eye (GO:0060041) | 5.03069391 |
34 | * detection of external stimulus (GO:0009581) | 5.01219341 |
35 | C21-steroid hormone biosynthetic process (GO:0006700) | 4.97351455 |
36 | * detection of abiotic stimulus (GO:0009582) | 4.95473057 |
37 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 4.91738787 |
38 | regulation of cGMP metabolic process (GO:0030823) | 4.83316803 |
39 | intermediate filament cytoskeleton organization (GO:0045104) | 4.79717929 |
40 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 4.72771387 |
41 | response to phenylpropanoid (GO:0080184) | 4.66152810 |
42 | intermediate filament-based process (GO:0045103) | 4.61051751 |
43 | androgen biosynthetic process (GO:0006702) | 4.60193816 |
44 | positive regulation of cGMP biosynthetic process (GO:0030828) | 4.48553845 |
45 | response to follicle-stimulating hormone (GO:0032354) | 4.44984985 |
46 | gap junction assembly (GO:0016264) | 4.38506501 |
47 | nonmotile primary cilium assembly (GO:0035058) | 4.33050675 |
48 | glucocorticoid biosynthetic process (GO:0006704) | 4.29704838 |
49 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 4.26568952 |
50 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 4.19897192 |
51 | progesterone metabolic process (GO:0042448) | 4.16527099 |
52 | regulation of cGMP biosynthetic process (GO:0030826) | 4.16329964 |
53 | desmosome organization (GO:0002934) | 4.11053617 |
54 | glucocorticoid metabolic process (GO:0008211) | 4.08881986 |
55 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 4.02383260 |
56 | phospholipid efflux (GO:0033700) | 3.99383985 |
57 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.96675432 |
58 | positive regulation of cGMP metabolic process (GO:0030825) | 3.94970357 |
59 | regulation of G-protein coupled receptor protein signaling pathway (GO:0008277) | 3.80774249 |
60 | adaptation of signaling pathway (GO:0023058) | 3.77642341 |
61 | cellular response to toxic substance (GO:0097237) | 3.72399323 |
62 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.68301587 |
63 | inositol phosphate dephosphorylation (GO:0046855) | 3.68301587 |
64 | retina layer formation (GO:0010842) | 3.51854477 |
65 | behavioral response to ethanol (GO:0048149) | 3.51156714 |
66 | skin morphogenesis (GO:0043589) | 3.50818627 |
67 | L-ascorbic acid metabolic process (GO:0019852) | 3.50321147 |
68 | cellular response to radiation (GO:0071478) | 3.47789256 |
69 | Leydig cell differentiation (GO:0033327) | 3.44025259 |
70 | chemosensory behavior (GO:0007635) | 3.41584973 |
71 | C21-steroid hormone metabolic process (GO:0008207) | 3.40307214 |
72 | phospholipid catabolic process (GO:0009395) | 3.38121562 |
73 | arachidonic acid secretion (GO:0050482) | 3.35918521 |
74 | icosanoid secretion (GO:0032309) | 3.35918521 |
75 | short-term memory (GO:0007614) | 3.35470542 |
76 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.34632327 |
77 | * sensory perception (GO:0007600) | 3.32745500 |
78 | cellular response to gonadotropin stimulus (GO:0071371) | 3.32117380 |
79 | protein heterotetramerization (GO:0051290) | 3.30863138 |
80 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 3.30354247 |
81 | inositol phosphate catabolic process (GO:0071545) | 3.26646855 |
82 | platelet dense granule organization (GO:0060155) | 3.25772768 |
83 | sphingoid metabolic process (GO:0046519) | 3.25514243 |
84 | negative regulation of interferon-gamma production (GO:0032689) | 3.24659256 |
85 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.23746958 |
86 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.23746958 |
87 | regulation of cholesterol homeostasis (GO:2000188) | 3.22023520 |
88 | parturition (GO:0007567) | 3.21406062 |
89 | positive regulation of glomerulus development (GO:0090193) | 3.20718511 |
90 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.19841634 |
91 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.17498957 |
92 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.17498957 |
93 | cellular response to cadmium ion (GO:0071276) | 3.16383600 |
94 | phosphatidylserine metabolic process (GO:0006658) | 3.16090596 |
95 | inositol metabolic process (GO:0006020) | 3.15231294 |
96 | transepithelial transport (GO:0070633) | 3.13043455 |
97 | response to insecticide (GO:0017085) | 3.12412061 |
98 | hair follicle morphogenesis (GO:0031069) | 3.12270688 |
99 | regulation of natural killer cell differentiation (GO:0032823) | 3.08494533 |
100 | hemidesmosome assembly (GO:0031581) | 3.07525247 |
101 | keratinocyte development (GO:0003334) | 3.05126453 |
102 | cullin deneddylation (GO:0010388) | 3.04728908 |
103 | regulation of penile erection (GO:0060405) | 3.04605971 |
104 | response to histamine (GO:0034776) | 3.03025110 |
105 | estrogen biosynthetic process (GO:0006703) | 2.98793786 |
106 | hormone biosynthetic process (GO:0042446) | 2.97538324 |
107 | ectoderm development (GO:0007398) | 2.97475720 |
108 | retina homeostasis (GO:0001895) | 2.93149023 |
109 | protein localization to synapse (GO:0035418) | 2.92553408 |
110 | positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745) | 2.91502005 |
111 | benzene-containing compound metabolic process (GO:0042537) | 2.90272861 |
112 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.86191448 |
113 | negative regulation of interleukin-17 production (GO:0032700) | 2.84951216 |
114 | primary alcohol catabolic process (GO:0034310) | 2.83850860 |
115 | protein prenylation (GO:0018342) | 2.82833334 |
116 | prenylation (GO:0097354) | 2.82833334 |
117 | vitamin transmembrane transport (GO:0035461) | 2.82682858 |
118 | epithelium development (GO:0060429) | 2.79120885 |
119 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.78071466 |
120 | fatty acid elongation (GO:0030497) | 2.77989431 |
121 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.75545491 |
122 | neuron development (GO:0048666) | 2.74950255 |
123 | ceramide biosynthetic process (GO:0046513) | 2.74231251 |
124 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.73648836 |
125 | androgen metabolic process (GO:0008209) | 2.73398737 |
126 | icosanoid transport (GO:0071715) | 2.72641663 |
127 | fatty acid derivative transport (GO:1901571) | 2.72641663 |
128 | righting reflex (GO:0060013) | 2.72107183 |
129 | synaptic transmission, dopaminergic (GO:0001963) | 2.69795828 |
130 | endosome organization (GO:0007032) | 2.66675069 |
131 | fibrinolysis (GO:0042730) | 2.66002544 |
132 | alditol phosphate metabolic process (GO:0052646) | 2.65666048 |
133 | surfactant homeostasis (GO:0043129) | 2.64925639 |
134 | * response to light stimulus (GO:0009416) | 2.63704907 |
135 | very long-chain fatty acid metabolic process (GO:0000038) | 2.63603129 |
136 | chemical homeostasis within a tissue (GO:0048875) | 2.62127724 |
137 | retinal metabolic process (GO:0042574) | 2.61864698 |
138 | regulation of bile acid biosynthetic process (GO:0070857) | 2.61864679 |
139 | behavioral response to cocaine (GO:0048148) | 2.61191342 |
140 | establishment of skin barrier (GO:0061436) | 2.59705979 |
141 | regulation of neuron projection regeneration (GO:0070570) | 2.59134458 |
142 | regulation of axon regeneration (GO:0048679) | 2.59134458 |
143 | negative regulation of mast cell activation (GO:0033004) | 2.59132890 |
144 | response to methylmercury (GO:0051597) | 2.58690433 |
145 | cholesterol efflux (GO:0033344) | 2.58214051 |
146 | vitamin A metabolic process (GO:0006776) | 2.57349867 |
147 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.56714319 |
148 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.54578332 |
149 | positive regulation of cholesterol efflux (GO:0010875) | 2.52998446 |
150 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.52642015 |
151 | bile acid biosynthetic process (GO:0006699) | 2.52570472 |
152 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.50955620 |
153 | keratinization (GO:0031424) | 2.50389266 |
154 | sphingosine metabolic process (GO:0006670) | 2.50269501 |
155 | sensory perception of smell (GO:0007608) | 2.49169465 |
156 | detection of bacterium (GO:0016045) | 2.47167367 |
157 | regulation of phospholipase A2 activity (GO:0032429) | 2.47015900 |
158 | keratinocyte proliferation (GO:0043616) | 2.45226852 |
159 | positive regulation of neurotransmitter transport (GO:0051590) | 2.43830990 |
160 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.42586562 |
161 | detection of other organism (GO:0098543) | 2.40608729 |
162 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 2.37302043 |
163 | histone H3-K4 trimethylation (GO:0080182) | 2.34388831 |
164 | diol metabolic process (GO:0034311) | 2.34361572 |
165 | superoxide anion generation (GO:0042554) | 2.28668034 |
166 | startle response (GO:0001964) | 2.28241244 |
167 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 2.27273563 |
168 | regulation of ruffle assembly (GO:1900027) | 2.26092898 |
169 | membrane hyperpolarization (GO:0060081) | 2.23304792 |
170 | regulation of neurotransmitter uptake (GO:0051580) | 2.23143476 |
171 | axoneme assembly (GO:0035082) | 2.22773572 |
172 | positive regulation of respiratory burst (GO:0060267) | 2.22199656 |
173 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 2.16930475 |
174 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.14572771 |
175 | sensory perception of chemical stimulus (GO:0007606) | 2.13569605 |
176 | regulation of dopamine metabolic process (GO:0042053) | 2.12783948 |
177 | regulation of catecholamine metabolic process (GO:0042069) | 2.12783948 |
178 | positive regulation of membrane potential (GO:0045838) | 2.12244349 |
179 | detection of chemical stimulus involved in sensory perception (GO:0050907) | 2.11440045 |
180 | positive regulation of ERBB signaling pathway (GO:1901186) | 2.08167366 |
181 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 13.6807207 |
182 | rhodopsin mediated signaling pathway (GO:0016056) | 13.3193838 |
183 | regulation of water loss via skin (GO:0033561) | 13.0562091 |
184 | retinal cone cell development (GO:0046549) | 10.5298344 |
185 | hair cycle (GO:0042633) | 10.1821382 |
186 | molting cycle (GO:0042303) | 10.1821382 |
Rank | Gene Set | Z-score |
---|---|---|
1 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 4.05694047 |
2 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 3.29518847 |
3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.28410708 |
4 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.09855416 |
5 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.01127863 |
6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.00563111 |
7 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.77835863 |
8 | VDR_22108803_ChIP-Seq_LS180_Human | 2.51397967 |
9 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.26830271 |
10 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.23305482 |
11 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.19524901 |
12 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.17471136 |
13 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.16982749 |
14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.10001566 |
15 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.03916988 |
16 | TP63_23658742_ChIP-Seq_EP156T_Human | 2.03031372 |
17 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.02770485 |
18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.94575658 |
19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.93084669 |
20 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.92367635 |
21 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.92321751 |
22 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.89061058 |
23 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.86885647 |
24 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.86423971 |
25 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.85739378 |
26 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.83722465 |
27 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.79505784 |
28 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.78451292 |
29 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.75730412 |
30 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.75158179 |
31 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.74990600 |
32 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.74094626 |
33 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.73936092 |
34 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.65770145 |
35 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.65280548 |
36 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.65280548 |
37 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.65196590 |
38 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.64519196 |
39 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.61977932 |
40 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.60990881 |
41 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.58818344 |
42 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.55331678 |
43 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.55023570 |
44 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.54758334 |
45 | P300_19829295_ChIP-Seq_ESCs_Human | 1.54428590 |
46 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.52711589 |
47 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.50344618 |
48 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.50328920 |
49 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.49041125 |
50 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.48402779 |
51 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.47491287 |
52 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.47444970 |
53 | RXR_22108803_ChIP-Seq_LS180_Human | 1.47410781 |
54 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.47204546 |
55 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.46604967 |
56 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.46176945 |
57 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.44869247 |
58 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.43716737 |
59 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.43597309 |
60 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.40427169 |
61 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.37576127 |
62 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.37209246 |
63 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.36660963 |
64 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.36193570 |
65 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.36189739 |
66 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.35287798 |
67 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.35285876 |
68 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.35180727 |
69 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.34928645 |
70 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.34490070 |
71 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.34412536 |
72 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.34328963 |
73 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.34090507 |
74 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.32733939 |
75 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.32419242 |
76 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.32188207 |
77 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.31329345 |
78 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.29282588 |
79 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.28150436 |
80 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.28145801 |
81 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.27064891 |
82 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.26716626 |
83 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.26385150 |
84 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.26124738 |
85 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.25375979 |
86 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.25158669 |
87 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.24933553 |
88 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.24933553 |
89 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.23802831 |
90 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.22606653 |
91 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.21863031 |
92 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.21758847 |
93 | FUS_26573619_Chip-Seq_HEK293_Human | 1.21508173 |
94 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.20891572 |
95 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.19571172 |
96 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.19457312 |
97 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.18171051 |
98 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.17703107 |
99 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.17446601 |
100 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.16940164 |
101 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.16543249 |
102 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.15856426 |
103 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.14265376 |
104 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.14042481 |
105 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.13963791 |
106 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.13559336 |
107 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.13559336 |
108 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.13395513 |
109 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.12503007 |
110 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.11948629 |
111 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.11265027 |
112 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.10587397 |
113 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.10510026 |
114 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.09296102 |
115 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.08659149 |
116 | KDM2B_26808549_Chip-Seq_REH_Human | 1.08601932 |
117 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.07789747 |
118 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.07600040 |
119 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.06825375 |
120 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.06470476 |
121 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.05850060 |
122 | AR_25329375_ChIP-Seq_VCAP_Human | 1.05805128 |
123 | TBL1_22424771_ChIP-Seq_293T_Human | 1.05427431 |
124 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.05416880 |
125 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.05351730 |
126 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.05297757 |
127 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.05291028 |
128 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05139010 |
129 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.05051284 |
130 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.04605284 |
131 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.04171105 |
132 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.04096579 |
133 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.03922746 |
134 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.03310166 |
135 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.02634900 |
136 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.01893002 |
137 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.01874695 |
138 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.01706005 |
139 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01706005 |
140 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.01571265 |
141 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.01571265 |
142 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.01563637 |
143 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01511461 |
144 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.01213784 |
145 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.00770928 |
146 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.00698918 |
147 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.00698918 |
148 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.99893912 |
149 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.99127448 |
150 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.98272628 |
151 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.98238595 |
152 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98177928 |
153 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.96880854 |
154 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.94414955 |
155 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.94403760 |
156 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.93140384 |
157 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.91962949 |
158 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.91167604 |
159 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.90739019 |
160 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.89051340 |
161 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.87430875 |
162 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.87427865 |
163 | AR_20517297_ChIP-Seq_VCAP_Human | 0.86641092 |
164 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.85879156 |
165 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.85744164 |
166 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.83799184 |
167 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.83507179 |
168 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.83223539 |
169 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.82009010 |
170 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.81466310 |
171 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81384630 |
172 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.80508711 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * MP0005551_abnormal_eye_electrophysiolog | 8.16055304 |
2 | * MP0003011_delayed_dark_adaptation | 7.14440709 |
3 | MP0005275_abnormal_skin_tensile | 6.64599446 |
4 | * MP0005253_abnormal_eye_physiology | 5.78167370 |
5 | MP0010234_abnormal_vibrissa_follicle | 5.15233743 |
6 | * MP0006072_abnormal_retinal_apoptosis | 4.99818929 |
7 | MP0003950_abnormal_plasma_membrane | 4.31768867 |
8 | MP0009379_abnormal_foot_pigmentation | 3.91943767 |
9 | MP0001986_abnormal_taste_sensitivity | 3.18134007 |
10 | * MP0005195_abnormal_posterior_eye | 3.09606238 |
11 | MP0002638_abnormal_pupillary_reflex | 2.90225813 |
12 | MP0005423_abnormal_somatic_nervous | 2.83770846 |
13 | MP0001324_abnormal_eye_pigmentation | 2.77852643 |
14 | MP0005083_abnormal_biliary_tract | 2.65572565 |
15 | * MP0005391_vision/eye_phenotype | 2.64281870 |
16 | MP0004381_abnormal_hair_follicle | 2.64109524 |
17 | MP0002090_abnormal_vision | 2.08355208 |
18 | MP0005365_abnormal_bile_salt | 2.04958376 |
19 | MP0002796_impaired_skin_barrier | 1.94540027 |
20 | MP0002229_neurodegeneration | 1.91234435 |
21 | MP0005451_abnormal_body_composition | 1.78911464 |
22 | MP0002102_abnormal_ear_morphology | 1.77783498 |
23 | MP0005085_abnormal_gallbladder_physiolo | 1.73932872 |
24 | MP0003880_abnormal_central_pattern | 1.73135872 |
25 | * MP0002752_abnormal_somatic_nervous | 1.72758158 |
26 | MP0003878_abnormal_ear_physiology | 1.72135553 |
27 | MP0005377_hearing/vestibular/ear_phenot | 1.72135553 |
28 | MP0002909_abnormal_adrenal_gland | 1.62162874 |
29 | MP0001188_hyperpigmentation | 1.62077817 |
30 | MP0003191_abnormal_cellular_cholesterol | 1.59486679 |
31 | MP0001984_abnormal_olfaction | 1.58697488 |
32 | MP0006292_abnormal_olfactory_placode | 1.55280228 |
33 | MP0003136_yellow_coat_color | 1.53787506 |
34 | MP0002095_abnormal_skin_pigmentation | 1.48978385 |
35 | MP0010386_abnormal_urinary_bladder | 1.43070245 |
36 | MP0003566_abnormal_cell_adhesion | 1.42824889 |
37 | MP0009931_abnormal_skin_appearance | 1.36787022 |
38 | MP0005409_darkened_coat_color | 1.35299693 |
39 | MP0000579_abnormal_nail_morphology | 1.34694038 |
40 | MP0001764_abnormal_homeostasis | 1.30801553 |
41 | MP0005501_abnormal_skin_physiology | 1.29489555 |
42 | MP0004019_abnormal_vitamin_homeostasis | 1.28298983 |
43 | MP0000383_abnormal_hair_follicle | 1.28225060 |
44 | MP0000367_abnormal_coat/_hair | 1.26974320 |
45 | MP0001486_abnormal_startle_reflex | 1.21323218 |
46 | MP0000647_abnormal_sebaceous_gland | 1.18772538 |
47 | MP0002277_abnormal_respiratory_mucosa | 1.14480997 |
48 | * MP0002882_abnormal_neuron_morphology | 1.06545593 |
49 | MP0004742_abnormal_vestibular_system | 1.05038743 |
50 | MP0003705_abnormal_hypodermis_morpholog | 1.04455681 |
51 | MP0008875_abnormal_xenobiotic_pharmacok | 1.04211949 |
52 | MP0000639_abnormal_adrenal_gland | 1.03089111 |
53 | MP0003941_abnormal_skin_development | 1.01680017 |
54 | MP0005084_abnormal_gallbladder_morpholo | 1.01658064 |
55 | MP0001216_abnormal_epidermal_layer | 1.01541356 |
56 | MP0005174_abnormal_tail_pigmentation | 1.01360895 |
57 | MP0008004_abnormal_stomach_pH | 0.99972512 |
58 | MP0002254_reproductive_system_inflammat | 0.99931553 |
59 | MP0004264_abnormal_extraembryonic_tissu | 0.98917613 |
60 | MP0009672_abnormal_birth_weight | 0.96797029 |
61 | MP0001502_abnormal_circadian_rhythm | 0.96617849 |
62 | MP0000465_gastrointestinal_hemorrhage | 0.96550064 |
63 | MP0010771_integument_phenotype | 0.95023903 |
64 | MP0001243_abnormal_dermal_layer | 0.94841586 |
65 | MP0001346_abnormal_lacrimal_gland | 0.93729317 |
66 | MP0000015_abnormal_ear_pigmentation | 0.93230895 |
67 | MP0003436_decreased_susceptibility_to | 0.92946144 |
68 | MP0002272_abnormal_nervous_system | 0.92642196 |
69 | MP0002098_abnormal_vibrissa_morphology | 0.90289099 |
70 | MP0003122_maternal_imprinting | 0.89691586 |
71 | MP0008260_abnormal_autophagy | 0.88014204 |
72 | MP0000427_abnormal_hair_cycle | 0.87364675 |
73 | MP0002009_preneoplasia | 0.86658221 |
74 | MP0004782_abnormal_surfactant_physiolog | 0.86256821 |
75 | MP0004043_abnormal_pH_regulation | 0.85337151 |
76 | MP0010678_abnormal_skin_adnexa | 0.84758568 |
77 | MP0002060_abnormal_skin_morphology | 0.83052586 |
78 | MP0009780_abnormal_chondrocyte_physiolo | 0.80034667 |
79 | MP0002148_abnormal_hypersensitivity_rea | 0.78904098 |
80 | MP0005499_abnormal_olfactory_system | 0.78738963 |
81 | MP0005394_taste/olfaction_phenotype | 0.78738963 |
82 | MP0001835_abnormal_antigen_presentation | 0.78634668 |
83 | MP0005379_endocrine/exocrine_gland_phen | 0.78606099 |
84 | MP0000026_abnormal_inner_ear | 0.77677393 |
85 | MP0008789_abnormal_olfactory_epithelium | 0.77305277 |
86 | MP0002139_abnormal_hepatobiliary_system | 0.76642310 |
87 | MP0006035_abnormal_mitochondrial_morpho | 0.76134808 |
88 | MP0003453_abnormal_keratinocyte_physiol | 0.76018990 |
89 | MP0008569_lethality_at_weaning | 0.75199818 |
90 | MP0002332_abnormal_exercise_endurance | 0.74960172 |
91 | MP0004885_abnormal_endolymph | 0.74795514 |
92 | MP0005197_abnormal_uvea_morphology | 0.73739216 |
93 | MP0000377_abnormal_hair_follicle | 0.73582010 |
94 | MP0001963_abnormal_hearing_physiology | 0.72553276 |
95 | MP0001851_eye_inflammation | 0.71695399 |
96 | MP0003045_fibrosis | 0.71672915 |
97 | MP0001968_abnormal_touch/_nociception | 0.71548226 |
98 | MP0000762_abnormal_tongue_morphology | 0.71070753 |
99 | MP0001501_abnormal_sleep_pattern | 0.70024258 |
100 | MP0005387_immune_system_phenotype | 0.68661743 |
101 | MP0001790_abnormal_immune_system | 0.68661743 |
102 | MP0009046_muscle_twitch | 0.68192435 |
103 | MP0005075_abnormal_melanosome_morpholog | 0.64428871 |
104 | MP0001905_abnormal_dopamine_level | 0.64387353 |
105 | MP0009745_abnormal_behavioral_response | 0.64328160 |
106 | MP0003315_abnormal_perineum_morphology | 0.64255670 |
107 | MP0001800_abnormal_humoral_immune | 0.62313083 |
108 | MP0004142_abnormal_muscle_tone | 0.61530956 |
109 | MP0002067_abnormal_sensory_capabilities | 0.60545076 |
110 | MP0004947_skin_inflammation | 0.59449448 |
111 | MP0009785_altered_susceptibility_to | 0.58157682 |
112 | MP0000566_synostosis | 0.57975462 |
113 | MP0002064_seizures | 0.57886636 |
114 | MP0009840_abnormal_foam_cell | 0.57505580 |
115 | MP0003183_abnormal_peptide_metabolism | 0.57479990 |
116 | MP0002177_abnormal_outer_ear | 0.56555471 |
117 | MP0010352_gastrointestinal_tract_polyps | 0.56141450 |
118 | MP0002419_abnormal_innate_immunity | 0.56070132 |
119 | MP0002132_abnormal_respiratory_system | 0.55840830 |
120 | MP0005671_abnormal_response_to | 0.53103949 |
121 | MP0002452_abnormal_antigen_presenting | 0.53058993 |
122 | MP0002572_abnormal_emotion/affect_behav | 0.52120695 |
123 | MP0002138_abnormal_hepatobiliary_system | 0.50657718 |
124 | MP0001191_abnormal_skin_condition | 0.50204809 |
125 | MP0005000_abnormal_immune_tolerance | 0.50178261 |
126 | MP0002735_abnormal_chemical_nociception | 0.49760640 |
127 | MP0005310_abnormal_salivary_gland | 0.49324607 |
128 | MP0002127_abnormal_cardiovascular_syste | 0.48860965 |
129 | MP0002723_abnormal_immune_serum | 0.48527599 |
130 | MP0003634_abnormal_glial_cell | 0.47669831 |
131 | MP0005025_abnormal_response_to | 0.47307158 |
132 | MP0002734_abnormal_mechanical_nocicepti | 0.46659875 |
133 | MP0000467_abnormal_esophagus_morphology | 0.46205344 |
134 | MP0010368_abnormal_lymphatic_system | 0.45725102 |
135 | MP0001765_abnormal_ion_homeostasis | 0.45338649 |
136 | MP0005187_abnormal_penis_morphology | 0.45136871 |
137 | MP0009764_decreased_sensitivity_to | 0.44244429 |
138 | MP0003635_abnormal_synaptic_transmissio | 0.44182541 |
139 | MP0003868_abnormal_feces_composition | 0.42237828 |
140 | MP0001340_abnormal_eyelid_morphology | 0.42057530 |
141 | MP0001440_abnormal_grooming_behavior | 0.41899949 |
142 | MP0005636_abnormal_mineral_homeostasis | 0.38572680 |
143 | MP0010329_abnormal_lipoprotein_level | 0.37409952 |
144 | MP0001186_pigmentation_phenotype | 0.36607385 |
145 | MP0002118_abnormal_lipid_homeostasis | 0.35048876 |
146 | MP0001784_abnormal_fluid_regulation | 0.34938572 |
147 | MP0001661_extended_life_span | 0.34596672 |
148 | MP0001756_abnormal_urination | 0.34277040 |
149 | MP0000372_irregular_coat_pigmentation | 0.32585454 |
150 | MP0005023_abnormal_wound_healing | 0.31893935 |
151 | MP0001485_abnormal_pinna_reflex | 0.31747146 |
152 | MP0005647_abnormal_sex_gland | 0.30676123 |
153 | MP0005332_abnormal_amino_acid | 0.30320342 |
154 | MP0003195_calcinosis | 0.29072109 |
155 | MP0008995_early_reproductive_senescence | 0.25918750 |
156 | MP0003638_abnormal_response/metabolism_ | 0.24350001 |
157 | MP0005408_hypopigmentation | 0.21589655 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of nail color (HP:0100643) | 9.94553623 |
2 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 9.22711215 |
3 | Abnormal rod and cone electroretinograms (HP:0008323) | 9.18121813 |
4 | Palmar hyperkeratosis (HP:0010765) | 7.82863524 |
5 | Pigmentary retinal degeneration (HP:0001146) | 7.63093391 |
6 | Attenuation of retinal blood vessels (HP:0007843) | 7.57494111 |
7 | Chorioretinal atrophy (HP:0000533) | 7.26238088 |
8 | Pendular nystagmus (HP:0012043) | 6.24393247 |
9 | Abnormality of macular pigmentation (HP:0008002) | 6.19026553 |
10 | Central scotoma (HP:0000603) | 6.14844102 |
11 | Decreased central vision (HP:0007663) | 6.01991128 |
12 | Dyschromatopsia (HP:0007641) | 5.84763126 |
13 | Oral leukoplakia (HP:0002745) | 5.80013463 |
14 | Scotoma (HP:0000575) | 5.49543955 |
15 | Abolished electroretinogram (ERG) (HP:0000550) | 5.40416096 |
16 | Alopecia of scalp (HP:0002293) | 5.39693563 |
17 | Thick nail (HP:0001805) | 5.14755441 |
18 | * Photophobia (HP:0000613) | 5.01162142 |
19 | Corneal erosion (HP:0200020) | 4.98480588 |
20 | Conjunctival hamartoma (HP:0100780) | 4.94801866 |
21 | Keratoconus (HP:0000563) | 4.78014715 |
22 | Increased corneal curvature (HP:0100692) | 4.78014715 |
23 | Absent eyelashes (HP:0000561) | 4.59242841 |
24 | * Type II diabetes mellitus (HP:0005978) | 4.56007259 |
25 | Woolly hair (HP:0002224) | 4.50807573 |
26 | Retinitis pigmentosa (HP:0000510) | 4.15923162 |
27 | Macular degeneration (HP:0000608) | 4.14642475 |
28 | Palmoplantar keratoderma (HP:0000982) | 4.03351809 |
29 | Cone-rod dystrophy (HP:0000548) | 3.97618271 |
30 | Absent hair (HP:0002298) | 3.90964323 |
31 | Severe visual impairment (HP:0001141) | 3.90182749 |
32 | Gangrene (HP:0100758) | 3.82987709 |
33 | Sparse eyelashes (HP:0000653) | 3.66171685 |
34 | Fragile nails (HP:0001808) | 3.64255819 |
35 | Vitreoretinal degeneration (HP:0000655) | 3.63558816 |
36 | Choroideremia (HP:0001139) | 3.59029569 |
37 | Pili torti (HP:0003777) | 3.44975676 |
38 | Nail dystrophy (HP:0008404) | 3.43250627 |
39 | Constricted visual fields (HP:0001133) | 3.30924728 |
40 | Congenital sensorineural hearing impairment (HP:0008527) | 3.23824436 |
41 | Right ventricular cardiomyopathy (HP:0011663) | 3.22930319 |
42 | Hamartoma of the eye (HP:0010568) | 3.18129924 |
43 | Abnormality of the salivary glands (HP:0010286) | 3.04157419 |
44 | Abnormal blistering of the skin (HP:0008066) | 3.00490955 |
45 | Abnormal hair laboratory examination (HP:0003328) | 2.96454009 |
46 | Renal salt wasting (HP:0000127) | 2.88304539 |
47 | Brittle hair (HP:0002299) | 2.77476040 |
48 | Eczematoid dermatitis (HP:0000976) | 2.77322237 |
49 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.76873090 |
50 | Pruritus (HP:0000989) | 2.68229573 |
51 | Progressive visual loss (HP:0000529) | 2.66511671 |
52 | Sparse scalp hair (HP:0002209) | 2.62066223 |
53 | Lack of skin elasticity (HP:0100679) | 2.49264276 |
54 | Furrowed tongue (HP:0000221) | 2.44771554 |
55 | Optic disc pallor (HP:0000543) | 2.43553133 |
56 | Gait imbalance (HP:0002141) | 2.42301467 |
57 | Congenital primary aphakia (HP:0007707) | 2.40242943 |
58 | Abnormality of hair growth rate (HP:0011363) | 2.37502990 |
59 | Slow-growing hair (HP:0002217) | 2.37502990 |
60 | Posterior subcapsular cataract (HP:0007787) | 2.36128330 |
61 | Parakeratosis (HP:0001036) | 2.34738860 |
62 | Dry hair (HP:0011359) | 2.33809425 |
63 | Follicular hyperkeratosis (HP:0007502) | 2.32855868 |
64 | Medial flaring of the eyebrow (HP:0010747) | 2.30007572 |
65 | Nephrogenic diabetes insipidus (HP:0009806) | 2.22576840 |
66 | Blepharitis (HP:0000498) | 2.16101192 |
67 | Absent eyebrow (HP:0002223) | 2.12371999 |
68 | * Wide nasal bridge (HP:0000431) | 2.02736172 |
69 | Amniotic constriction ring (HP:0009775) | 2.00380624 |
70 | Abnormality of placental membranes (HP:0011409) | 2.00380624 |
71 | Congenital stationary night blindness (HP:0007642) | 14.5463164 |
72 | Bony spicule pigmentary retinopathy (HP:0007737) | 10.5460875 |
73 | Abnormality of the lacrimal duct (HP:0011481) | 1.94481928 |
74 | Lip pit (HP:0100267) | 1.91733937 |
75 | Septo-optic dysplasia (HP:0100842) | 1.91549591 |
76 | Pustule (HP:0200039) | 1.91286371 |
77 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.89127530 |
78 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.87140995 |
79 | Hypoplastic labia majora (HP:0000059) | 1.86556061 |
80 | Vaginal atresia (HP:0000148) | 1.84921259 |
81 | True hermaphroditism (HP:0010459) | 1.83975845 |
82 | Hyperhidrosis (HP:0000975) | 1.82842242 |
83 | Dehydration (HP:0001944) | 1.82125820 |
84 | Ridged nail (HP:0001807) | 1.80603338 |
85 | Dysdiadochokinesis (HP:0002075) | 1.80256676 |
86 | Genital tract atresia (HP:0001827) | 1.79767532 |
87 | Hypergammaglobulinemia (HP:0010702) | 1.79736157 |
88 | Recurrent sinusitis (HP:0011108) | 1.78819129 |
89 | Azoospermia (HP:0000027) | 1.77989878 |
90 | Melanocytic nevus (HP:0000995) | 1.77726785 |
91 | Taurodontia (HP:0000679) | 1.76799849 |
92 | Abnormality of permanent molar morphology (HP:0011071) | 1.76799849 |
93 | Abnormality of the dental root (HP:0006486) | 1.76799849 |
94 | Febrile seizures (HP:0002373) | 1.75681524 |
95 | Selective tooth agenesis (HP:0001592) | 1.74622083 |
96 | Poor coordination (HP:0002370) | 1.73258690 |
97 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.71859525 |
98 | Advanced eruption of teeth (HP:0006288) | 1.71289057 |
99 | Autoamputation (HP:0001218) | 1.70782672 |
100 | Dry skin (HP:0000958) | 1.68153405 |
101 | Labial hypoplasia (HP:0000066) | 1.67673991 |
102 | Hypotrichosis (HP:0001006) | 1.66725854 |
103 | Premature ovarian failure (HP:0008209) | 1.65307539 |
104 | Abnormality of the labia majora (HP:0012881) | 1.64780037 |
105 | Retinal atrophy (HP:0001105) | 1.64631975 |
106 | Septate vagina (HP:0001153) | 1.64323990 |
107 | Abnormality of the nasolacrimal system (HP:0000614) | 1.63649040 |
108 | Abnormality of molar morphology (HP:0011070) | 1.62357580 |
109 | Abnormality of molar (HP:0011077) | 1.62357580 |
110 | Increased IgE level (HP:0003212) | 1.62049434 |
111 | Interstitial pulmonary disease (HP:0006530) | 1.61429093 |
112 | Erythema (HP:0010783) | 1.59968574 |
113 | Hyperaldosteronism (HP:0000859) | 1.58989688 |
114 | Fine hair (HP:0002213) | 1.58833614 |
115 | Action tremor (HP:0002345) | 1.57501120 |
116 | Urticaria (HP:0001025) | 1.57451109 |
117 | Myokymia (HP:0002411) | 1.57016010 |
118 | Abnormality of the dental pulp (HP:0006479) | 1.56066880 |
119 | Chromsome breakage (HP:0040012) | 1.55655371 |
120 | Hypoplastic female external genitalia (HP:0012815) | 1.55155024 |
121 | Milia (HP:0001056) | 1.54625467 |
122 | Natal tooth (HP:0000695) | 1.54111495 |
123 | Laryngomalacia (HP:0001601) | 1.53868389 |
124 | Recurrent corneal erosions (HP:0000495) | 1.53015919 |
125 | Nasolacrimal duct obstruction (HP:0000579) | 1.51410566 |
126 | Hamartoma (HP:0010566) | 1.49831826 |
127 | Astigmatism (HP:0000483) | 1.47082761 |
128 | Severe Myopia (HP:0011003) | 1.46923044 |
129 | Intention tremor (HP:0002080) | 1.46763769 |
130 | Conical tooth (HP:0000698) | 1.46104806 |
131 | Epidermoid cyst (HP:0200040) | 1.45686136 |
132 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.44733075 |
133 | Aplasia of the phalanges of the hand (HP:0009802) | 1.44733075 |
134 | Aplasia involving bones of the extremities (HP:0009825) | 1.44733075 |
135 | Corneal dystrophy (HP:0001131) | 1.44240865 |
136 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.43184279 |
137 | Multifactorial inheritance (HP:0001426) | 1.42861148 |
138 | Retrobulbar optic neuritis (HP:0100654) | 1.42697419 |
139 | Optic neuritis (HP:0100653) | 1.42697419 |
140 | Abnormality of dental color (HP:0011073) | 1.42381453 |
141 | Subcapsular cataract (HP:0000523) | 1.41373457 |
142 | Asthma (HP:0002099) | 1.40623782 |
143 | Hypoplasia of the fovea (HP:0007750) | 1.38776679 |
144 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.38776679 |
145 | Ectropion (HP:0000656) | 1.38366303 |
146 | Abnormality of the axillary hair (HP:0100134) | 1.38310292 |
147 | Abnormality of secondary sexual hair (HP:0009888) | 1.38310292 |
148 | Xerostomia (HP:0000217) | 1.37574866 |
149 | Acanthosis nigricans (HP:0000956) | 1.36558545 |
150 | Upper limb muscle weakness (HP:0003484) | 1.34846922 |
151 | Pancreatic fibrosis (HP:0100732) | 1.34316761 |
152 | Prostate neoplasm (HP:0100787) | 1.33892432 |
153 | * Optic atrophy (HP:0000648) | 1.31682637 |
154 | Plantar hyperkeratosis (HP:0007556) | 1.31342477 |
155 | Duplicated collecting system (HP:0000081) | 1.30793164 |
156 | Progressive cerebellar ataxia (HP:0002073) | 1.29942515 |
157 | Hypodontia (HP:0000668) | 1.29439210 |
158 | Chronic obstructive pulmonary disease (HP:0006510) | 1.25014158 |
159 | Obstructive lung disease (HP:0006536) | 1.25014158 |
160 | Chorioretinal coloboma (HP:0000567) | 1.24364383 |
161 | Abnormality of the fovea (HP:0000493) | 1.23576949 |
162 | Stomatitis (HP:0010280) | 1.21524886 |
163 | Absent septum pellucidum (HP:0001331) | 1.20690146 |
164 | Amelogenesis imperfecta (HP:0000705) | 1.20379689 |
165 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.19761298 |
166 | Abnormality of the renal collecting system (HP:0004742) | 1.19713927 |
167 | Focal motor seizures (HP:0011153) | 1.17574629 |
168 | Onycholysis (HP:0001806) | 1.17195441 |
169 | Agammaglobulinemia (HP:0004432) | 1.16211349 |
170 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.15338588 |
171 | Erythroderma (HP:0001019) | 1.15034965 |
172 | Recurrent abscess formation (HP:0002722) | 1.14067656 |
173 | Pancreatic cysts (HP:0001737) | 1.13473867 |
174 | Epileptic encephalopathy (HP:0200134) | 1.12839319 |
175 | Palmoplantar hyperkeratosis (HP:0000972) | 1.12315754 |
176 | Abnormal sex determination (HP:0012244) | 1.12256864 |
177 | Sex reversal (HP:0012245) | 1.12256864 |
178 | Hypohidrosis (HP:0000966) | 1.10183828 |
179 | Absent/shortened dynein arms (HP:0200106) | 1.08828637 |
180 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.08828637 |
181 | Male pseudohermaphroditism (HP:0000037) | 1.08446639 |
182 | Meningitis (HP:0001287) | 1.07893242 |
Rank | Gene Set | Z-score |
---|---|---|
1 | GRK1 | 7.47112102 |
2 | NME1 | 6.38913862 |
3 | PBK | 5.03569353 |
4 | TGFBR1 | 3.82713407 |
5 | STK24 | 3.39555348 |
6 | CASK | 3.39144956 |
7 | MAP3K9 | 2.98229065 |
8 | EIF2AK1 | 2.56643343 |
9 | MAPKAPK3 | 2.54993888 |
10 | FGFR1 | 2.54587971 |
11 | BLK | 2.45095619 |
12 | EPHA2 | 2.41602674 |
13 | EIF2AK3 | 2.24294345 |
14 | TNIK | 2.19487028 |
15 | IRAK2 | 2.09865559 |
16 | CAMK1D | 1.90662645 |
17 | FGFR3 | 1.82940917 |
18 | EEF2K | 1.78704591 |
19 | INSRR | 1.74286788 |
20 | TAOK3 | 1.70143921 |
21 | TNK2 | 1.64696503 |
22 | WNK3 | 1.61758949 |
23 | MYLK | 1.53814869 |
24 | AKT3 | 1.51861494 |
25 | RIPK4 | 1.49827289 |
26 | CDK3 | 1.48587498 |
27 | FES | 1.48406240 |
28 | IRAK4 | 1.42430399 |
29 | EPHA3 | 1.38873130 |
30 | GRK7 | 1.37810264 |
31 | PRKD3 | 1.30932349 |
32 | EPHA4 | 1.29696703 |
33 | BMPR1B | 1.26631960 |
34 | CLK1 | 1.23867109 |
35 | MAP3K14 | 1.23480349 |
36 | BMPR2 | 1.23251980 |
37 | EIF2AK2 | 1.21208920 |
38 | TTK | 1.21055820 |
39 | TSSK6 | 1.20261383 |
40 | ADRBK1 | 1.18610332 |
41 | PIK3CG | 1.18568936 |
42 | MUSK | 1.17531825 |
43 | FGFR4 | 1.17089081 |
44 | ERBB3 | 1.13953977 |
45 | MAP3K2 | 1.11184161 |
46 | ADRBK2 | 1.11116026 |
47 | PINK1 | 1.10140226 |
48 | IRAK1 | 1.06597791 |
49 | TEC | 1.04929589 |
50 | TXK | 1.04591435 |
51 | MKNK2 | 1.04472350 |
52 | BRD4 | 1.03897135 |
53 | NEK6 | 1.03817699 |
54 | TESK1 | 1.03633255 |
55 | FGR | 1.00997801 |
56 | MAPK7 | 1.00518764 |
57 | YES1 | 0.99788520 |
58 | PKN1 | 0.98449891 |
59 | STK16 | 0.97771016 |
60 | ABL2 | 0.97583832 |
61 | MAPKAPK5 | 0.97495582 |
62 | MAP3K13 | 0.96637216 |
63 | FRK | 0.95429272 |
64 | BTK | 0.95120263 |
65 | TRPM7 | 0.94936159 |
66 | EPHB2 | 0.93737640 |
67 | PIM2 | 0.90954285 |
68 | CCNB1 | 0.89966254 |
69 | MAPK12 | 0.85591468 |
70 | SIK2 | 0.85174041 |
71 | ACVR1B | 0.84428930 |
72 | EPHB1 | 0.84415873 |
73 | ARAF | 0.84297400 |
74 | MST4 | 0.80636601 |
75 | MST1R | 0.76634079 |
76 | RPS6KB1 | 0.74837954 |
77 | STK3 | 0.74820631 |
78 | DYRK1A | 0.74398976 |
79 | MAP2K7 | 0.73582385 |
80 | PDK2 | 0.72576383 |
81 | MAPK13 | 0.71775768 |
82 | PRKCG | 0.70915481 |
83 | MAP2K6 | 0.70909410 |
84 | CAMK1G | 0.70323018 |
85 | STK38L | 0.68935465 |
86 | CSNK1G2 | 0.67862241 |
87 | MAP3K12 | 0.66867901 |
88 | MAP4K1 | 0.65517272 |
89 | HIPK2 | 0.64600418 |
90 | PRKCE | 0.64416226 |
91 | LATS1 | 0.64071503 |
92 | STK11 | 0.63866141 |
93 | STK39 | 0.63822483 |
94 | PRPF4B | 0.63663975 |
95 | SGK2 | 0.62902714 |
96 | BRAF | 0.62287129 |
97 | CSK | 0.61151527 |
98 | IKBKE | 0.61069538 |
99 | SYK | 0.60091082 |
100 | HCK | 0.59775227 |
101 | FER | 0.59548309 |
102 | CSNK1G1 | 0.59536213 |
103 | CAMK2A | 0.59227260 |
104 | DYRK3 | 0.59124757 |
105 | LYN | 0.58329055 |
106 | PAK4 | 0.58179565 |
107 | MARK2 | 0.57645021 |
108 | MAP2K4 | 0.57626581 |
109 | BCR | 0.56876269 |
110 | MAP3K3 | 0.56599406 |
111 | RPS6KA5 | 0.55896709 |
112 | CAMKK2 | 0.55469868 |
113 | SGK3 | 0.55412020 |
114 | MAP3K6 | 0.55319059 |
115 | ITK | 0.55178025 |
116 | FGFR2 | 0.55049640 |
117 | IRAK3 | 0.54294569 |
118 | CAMK1 | 0.54289411 |
119 | SGK223 | 0.51989784 |
120 | SGK494 | 0.51989784 |
121 | NME2 | 0.51969799 |
122 | IKBKB | 0.51948930 |
123 | PRKCZ | 0.51745270 |
124 | MAP3K5 | 0.51688624 |
125 | GRK5 | 0.51181107 |
126 | MET | 0.50822062 |
127 | CSNK1G3 | 0.50182523 |
128 | LATS2 | 0.49885954 |
129 | NLK | 0.49719375 |
130 | CSNK1D | 0.48923489 |
131 | NTRK2 | 0.48393628 |
132 | PRKD2 | 0.48011704 |
133 | PRKCQ | 0.47498259 |
134 | TGFBR2 | 0.46669283 |
135 | NTRK3 | 0.46634913 |
136 | CSNK1A1L | 0.45276867 |
137 | CSNK1E | 0.44327569 |
138 | PRKCB | 0.44234795 |
139 | NUAK1 | 0.44055231 |
140 | TIE1 | 0.43917973 |
141 | OXSR1 | 0.43607970 |
142 | SGK1 | 0.43183319 |
143 | MOS | 0.43130050 |
144 | PRKAA2 | 0.43097606 |
145 | LCK | 0.42214714 |
146 | FYN | 0.42191890 |
147 | ZAK | 0.41201826 |
148 | PNCK | 0.39562652 |
149 | PRKACA | 0.38889887 |
150 | WNK1 | 0.38836424 |
151 | JAK1 | 0.38465579 |
152 | PRKG1 | 0.36522913 |
153 | TAOK2 | 0.36288950 |
154 | RPS6KB2 | 0.35549929 |
155 | CAMK2D | 0.34982912 |
156 | DYRK2 | 0.34964175 |
157 | GSK3A | 0.34876476 |
158 | CDK9 | 0.34461871 |
159 | MAPKAPK2 | 0.34306633 |
160 | RPS6KA4 | 0.34041483 |
161 | MKNK1 | 0.33205836 |
162 | CDK6 | 0.30788751 |
163 | CDK7 | 0.29786488 |
164 | PTK2 | 0.29311989 |
165 | RIPK1 | 0.28386223 |
166 | MINK1 | 0.27481470 |
167 | AKT2 | 0.26271846 |
168 | DAPK1 | 0.26238695 |
169 | MAP3K1 | 0.23901578 |
170 | TAF1 | 0.23113446 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.57464212 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.26944432 |
3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.19934190 |
4 | Phototransduction_Homo sapiens_hsa04744 | 13.6100307 |
5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.97904041 |
6 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.79484833 |
7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.69985893 |
8 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.57785884 |
9 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.55968286 |
10 | Olfactory transduction_Homo sapiens_hsa04740 | 1.52864094 |
11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.47979808 |
12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.47675028 |
13 | Nicotine addiction_Homo sapiens_hsa05033 | 1.41638487 |
14 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.36953520 |
15 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.36267384 |
16 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.32140457 |
17 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.30493212 |
18 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.29890226 |
19 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.27054073 |
20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.25055926 |
21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.24928884 |
22 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.22001435 |
23 | Morphine addiction_Homo sapiens_hsa05032 | 1.21013082 |
24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.19149161 |
25 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.17819994 |
26 | GABAergic synapse_Homo sapiens_hsa04727 | 1.15856041 |
27 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.14841698 |
28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.10274621 |
29 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.08415570 |
30 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.07705381 |
31 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.04669869 |
32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.04513309 |
33 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.03273008 |
34 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.00167849 |
35 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.97929155 |
36 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.97248791 |
37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.97168121 |
38 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.96021421 |
39 | Bile secretion_Homo sapiens_hsa04976 | 0.93411260 |
40 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.93269772 |
41 | Alzheimers disease_Homo sapiens_hsa05010 | 0.91650814 |
42 | Circadian entrainment_Homo sapiens_hsa04713 | 0.90694716 |
43 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.89351131 |
44 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.86994032 |
45 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.86937245 |
46 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.83144831 |
47 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81293787 |
48 | Circadian rhythm_Homo sapiens_hsa04710 | 0.78768938 |
49 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77746813 |
50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.77277773 |
51 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.75625103 |
52 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.75599941 |
53 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.75008987 |
54 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.74637719 |
55 | Parkinsons disease_Homo sapiens_hsa05012 | 0.71824994 |
56 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.71734492 |
57 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.70764524 |
58 | ABC transporters_Homo sapiens_hsa02010 | 0.69646619 |
59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.67499243 |
60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.67245185 |
61 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.67031877 |
62 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.66597497 |
63 | * Retinol metabolism_Homo sapiens_hsa00830 | 0.65520997 |
64 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.64483670 |
65 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.64256262 |
66 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.64217439 |
67 | Salivary secretion_Homo sapiens_hsa04970 | 0.63594251 |
68 | Taste transduction_Homo sapiens_hsa04742 | 0.63369161 |
69 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.63067915 |
70 | Renin secretion_Homo sapiens_hsa04924 | 0.62943999 |
71 | Asthma_Homo sapiens_hsa05310 | 0.61624108 |
72 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.61387288 |
73 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.61324895 |
74 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.61004017 |
75 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.60459321 |
76 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59004084 |
77 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.58562724 |
78 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.58246598 |
79 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.57939134 |
80 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.57710621 |
81 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.56754615 |
82 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.56614600 |
83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56425226 |
84 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.56276843 |
85 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54421421 |
86 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.53699745 |
87 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.50670159 |
88 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.50577375 |
89 | Allograft rejection_Homo sapiens_hsa05330 | 0.49076330 |
90 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48969063 |
91 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.48682569 |
92 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.46839003 |
93 | Axon guidance_Homo sapiens_hsa04360 | 0.46680591 |
94 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.46097949 |
95 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.46028260 |
96 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.44870212 |
97 | Leishmaniasis_Homo sapiens_hsa05140 | 0.44416407 |
98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.44401854 |
99 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43971442 |
100 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.43530891 |
101 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.43307958 |
102 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.43161542 |
103 | Lysosome_Homo sapiens_hsa04142 | 0.42418032 |
104 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.42282118 |
105 | Long-term depression_Homo sapiens_hsa04730 | 0.42260774 |
106 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.41799168 |
107 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.41125547 |
108 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.40605189 |
109 | Huntingtons disease_Homo sapiens_hsa05016 | 0.40529145 |
110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40164057 |
111 | Peroxisome_Homo sapiens_hsa04146 | 0.39701948 |
112 | Long-term potentiation_Homo sapiens_hsa04720 | 0.39508878 |
113 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39080412 |
114 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.38994526 |
115 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.38941482 |
116 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.38894153 |
117 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.38821504 |
118 | Malaria_Homo sapiens_hsa05144 | 0.37819075 |
119 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.36819664 |
120 | Insulin secretion_Homo sapiens_hsa04911 | 0.36601554 |
121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36394919 |
122 | Amoebiasis_Homo sapiens_hsa05146 | 0.36386577 |
123 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.35906924 |
124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.35162910 |
125 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.34570763 |
126 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.34494005 |
127 | Cocaine addiction_Homo sapiens_hsa05030 | 0.34052620 |
128 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.33517118 |
129 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.33464742 |
130 | Mineral absorption_Homo sapiens_hsa04978 | 0.32887740 |
131 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.32619758 |
132 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.32405955 |
133 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.31969743 |
134 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.31585904 |
135 | Tuberculosis_Homo sapiens_hsa05152 | 0.30969523 |
136 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.30759243 |
137 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.30683721 |
138 | Carbon metabolism_Homo sapiens_hsa01200 | 0.30139402 |
139 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.29214287 |
140 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.28314185 |
141 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.27681732 |
142 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.27261841 |
143 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.27201644 |
144 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.26833788 |
145 | Histidine metabolism_Homo sapiens_hsa00340 | 0.25598436 |
146 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.25563518 |
147 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.25454606 |
148 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.25386642 |
149 | Phagosome_Homo sapiens_hsa04145 | 0.24604416 |
150 | Measles_Homo sapiens_hsa05162 | 0.24105321 |
151 | Purine metabolism_Homo sapiens_hsa00230 | 0.23894627 |
152 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.23704627 |
153 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.23589950 |
154 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.21980083 |
155 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.21265603 |
156 | Alcoholism_Homo sapiens_hsa05034 | 0.20749600 |
157 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.20645479 |
158 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.20637293 |
159 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.19556073 |